1. Field of the Invention
This invention relates generally to devices and other apparatus facilitating sealed access with surgical instruments, such as a surgeon's hand, across a body wall and into a body cavity.
2. Background of the Invention
In several areas of surgery there exists a need to have mechanisms or devices that can seal a body cavity or space, and yet permit the introduction of surgical instruments such as guidewires, endoscopes, and even the hand of a surgeon. Typical of these areas of surgery is laparoscopic surgery which relies on surgical instruments inserted through the abdominal wall to reach an operative site within the abdominal cavity. In order to increase space around the operative site within the cavity, insufflation gases are typically introduced to inflate the cavity and elevate the abdominal wall. This pressurizing of the abdominal cavity is referred to as pneumoperitoneum. In this context, the need to seal the body cavity or space arises from the need to maintain the pneumoperitoneum even when instruments are present.
Trocars have been commonly used to provide instrument access in laparoscopic surgeries. These trocars have included elaborate seal structures having zero seals which prevent escape of the gases in the absence of instruments, and instrument seals which prevent escape of the gases in the presence of instruments. Unfortunately, the instrument seals have been able to accommodate only a narrow range of instrument diameters. Where wider ranges were desired multiple seal pairs had to be provided.
Some instruments, such as the hand of the surgeon, have been too large for trocar access. Under these circumstances, hand-assisted laparoscopic seals have been provided. Such devices have been large, cumbersome, and largely ineffective in providing the required sealing mechanism. Other access devices, such as Touhy-Borst seals, have been used but only for very small diameter access such as that required by a guidewire.
Each of the prior devices suffers from drawbacks which make the device difficult or cumbersome to use. For example, a Touhy-Borst seal requires two hands to use and does not form a seal when a guidewire or other device is about to be introduced. Present trocar seals and hand-assisted seals require two valves, one forming an instrument seal in the presence of the instrument, and the other forming a zero seal in the absence of the instrument. For example, in hand-assisted devices, elaborate mechanisms have been required to seal around the surgeon's arm. When the arm is removed, a separate zero seal has been required to prevent the escape of blood or insufflation gases.
These deficiencies of the prior art are overcome with the present invention which includes both a seal apparatus and a method for using this apparatus to perform elaborate surgeries. In one embodiment, the device includes a valve structure formed of a gel including, for example, a thermoplastic base such as KRATON (a trademark of Shell Corporation) and an oil. The resulting elastomer has an excellent tear strength, elongation greater than 1,000 percent, a very low durometer or hardness, and biocompatibility. A process for manufacturing this device is greatly simplified using molding techniques.
Importantly, the access device can function as both a zero seal and an instrument seal. Furthermore, it can accommodate a full range of instrument diameters, such as a range from two French in the case of a guidewire, to three or four inches in the case of a surgeon's hand. In addition, several instruments can be accommodated at the same time with a single access device.
Both tear resistance and sealing capability can be enhanced by encapsulating the gel in a sheath or otherwise providing circumferential reinforcement for the valve structure. Additives can be provided either on or in the gel to enhance properties such as lubricity, appearance, wound treatment and/or protection, anti-cancer protection and anti-microbial protection. Additional chemicals, compounds, pharmaceuticals or even mechanical devices can be mixed with or embedded in the gel material to vary chemical, pharmaceutical or physical properties of the access device.
These and other features and advantageous of the invention will be clarified with a description of preferred embodiments and reference to the associated drawings.
A patient is illustrated in
Although the specific focus of this disclosure will be on a preferred laparoscopic procedure, it will be noted that laparoscopic surgery is merely representative of a type of operation wherein a procedure can be performed in a body cavity with minimal access through a body wall.
Notwithstanding the foregoing generality, it is important to note that with respect to laparoscopic surgery, it is often desirable that the surgeon 14 be able to insert his/her hand 17 through the abdominal wall 21 and into the abdominal cavity 18. This insertion of the hand 17 provides the surgeon 14 with direct access to various elements of the anatomy
In order to accommodate the hand 17 and arm 16 of the surgeon 14, a small incision 32 is typically created in the abdominal wall 21. An access device 34 of the present invention can be provided to further facilitate this access by the hand of the surgeon 14.
Particularly in the case of laparoscopic surgery, it is advantageous to insufflate the abdominal cavity 18 with a gas, such as carbon dioxide, in order to elevate the abdominal wall 21 and thereby increase the volume of the working space within the cavity 18. Maintenance of this insufflation pressure, commonly referred to as pneumoperitoneum, is particularly difficult where access is desired across the abdominal wall 21, for example, through the trocars 23, 25, as well as the access device 34. For this reason, a substantial effort has been directed to providing such access devices with sealing characteristics both in the presence of instruments and in the absence of instruments, such as the grasper 29, scope 30 and hand 27.
Thus, the trocars 23 and 25 have typically been provided with complex valve structures, including, for each narrow range of instrument sizes, an instrument valve which forms an instrument seal in the presence of an instrument, and a zero valve which forms a zero seal in the absence of an instrument. By providing both an instrument seal and a zero seal the valve structures have been able to inhibit the escape of gases through the trocars both in the presence and the absence of an instrument, respectively.
The instrument seals have been particularly cumbersome, as noted, and have only been effective for a small range of instrument diameters. For example, separate instrument seals have been needed for instruments, such as guidewires, which may have a diameter of only two French to three French. For medium-sized instruments having diameters of three millimeter to five millimeters, a second instrument seal has been required. In some cases, even a third instrument seal has been necessary in order to accommodate instruments having diameters such as nine millimeters to 12 millimeters.
Typically the varying sizes of instruments have also required individual zero seals for each range. Thus, in a complex trocar, such as the trocar 23, there might be as many as six separate seals associated with the access device.
If not for the desire to maintain the pneumoperitoneum, there would be no need for the trocars 23, 25 or the access device 34. One would merely cut an incision in the abdominal wall 21 and insert the instrument directly through the incision. However, without appropriate valves or seals, the insufflation gases would merely escape through the incisions. This would be particularly detrimental in the case of the incision 32 which must be sufficiently large to accept the hand 17 of the surgeon 14. Thus it is a primary purpose of the access device 34 to form with the incision 32 an access or working channel 34, and to provide a valve or other sealing structure across the working channel 34 in order to maintain the pneumoperitoneum.
An enlarged view of one embodiment of the access device 34 is illustrated in
When operatively disposed, the opening 45 of the pad 35 is in communication with the incision 32 and, in this case, forms with the incision 32, the working channel 36. The alignment of the opening 45 and incision 32 can occur with the pad 35 disposed exteriorly of the abdominal wall as illustrated in
If this adhesive 50 is formed as a continuous ring 52, as illustrated in
The escape of insufflation gases is inhibited through the opening 45 of the pad 35 by the self-sealing characteristics of the material forming the pad 35. This material and its highly advantageous properties are discussed in significant detail below.
It will be appreciated that the functions of the adhesive ring 52 can be accomplished in many different ways using many different materials and shapes. For example, many materials other than adhesives can be used to maintain the pad 35 in position over the incision 32. The formation of a seal around the incision 32 can also be accomplished with methods other than adhesion. Furthermore, the shape of the continuous seal formed by the adhesive 50 need not be in the shape of a circle. Rather, any continuous pattern sufficiently large to form a perimeter around the incision 32 could facilitate the desired sealing relationship. Finally, it will be noted that the mere placement of the pad 35, for example, interiorly of the abdominal wall 21 as illustrated in
A further embodiment of the access device 34 is illustrated in
When operatively disposed, the external flange 54 is positioned outside of the abdominal wall 21 while the internal flange 56 is disposed interiorly of the abdominal wall 21a. In this matter, the pad 35 can be disposed within the incision 32a and held in position by the flanges 54, 56. When the hand 17 of the surgeon 14 is inserted through the access device 34, the exterior flange 54 prevents the pad 35a from moving distally. Similarly, when the hand 17 of the surgeon 14 is withdrawn, the interior flange 56 prevents the pad 35a from moving proximally
In this embodiment, the opening 45a extends through the pad 35a as well as the flanges 54 and 56, and completely defines the working channel 34 through the incision 32.
The primary seal which is required between the access device 34a and the abdominal wall 21, can be formed with the adhesive ring 52a as discussed with reference to
The function of the primary seal may be further enhanced by additional sealing which occurs between the pad 35a and the portions of the abdominal wall 21 forming the incision 32. In this location, the abdominal wall 21 is radially compressed by the mere presence of the pad 35 within the incision 32. The resulting pressure produces an axial seal between the pad 35a and the abdominal wall 21.
If the adhesive ring 52a is desired for this embodiment, it is most advantageously placed around the incision 32, between the exterior flange 54 and the abdominal wall 21.
It will be noted that whenever an instrument, such as the arm 16 or hand 17 of the surgeon 14, is inserted through the pad 35, the material of the pad conforms to the surface of the instrument and forms the instrument seal with the instrument. Accordingly, during the entire period beginning with insertion of the instrument and ending with withdrawal of the instrument, there is substantially no loss of insufflation gas through the pad 35a nor any loss of pneumoperitoneum within the abdominal cavity 18.
With further reference to
Formation of the pad 35a will typically be accomplished in a simple molding process described in greater detail below. In such a process, the opening or slit 45a may be formed as part of the molding process.
In most cases, the single access opening 45a will be sufficient to accommodate the operative procedure. However, a further advantage of the access device 34a will be particularly appreciated by the surgeon 14 who requires even more access through the pad 35a. Consider for example, the surgeon 14 having his/her arm 16 inserted through the opening 45a when he/she decides that a further instrument is required for the operative procedure. Under these circumstances, a further opening through the pad 35a can be established by merely inserting the desired operative instrument through the pad 35a. In this manner, the instrument can create its own access hole beside the primary opening 45a.
Particularly for those operative instruments having pointed distal ends, the instrument can merely be forced through the pad 35a forming its own access hole, such as the opening 45a, as it is moved distally. This opening, created by the operative instrument itself, would automatically form an instrument seal as the instrument is inserted, as well as a zero seal as the instrument is withdrawn.
For operative instruments not having pointed distal ends, it is possible to form a new access hole using a secondary instrument, such as a trocar obturator. After the access hole is formed, the obturator can be removed, vacating the access hole to receive the operative instrument. Throughout this process of initially forming an access hole and ultimately inserting an operative instrument through the hole, both zero seals and instrument seals are formed to maintain the pneumoperitoneum.
With the advantages associated with 1) the formation of an instrument seal and a zero seal with a single valve accommodating a wide range of diameters, and 2) the formation of an instrument opening using the instrument itself, it will be appreciated that the concept of this invention will typically be embodied with a structure that is particularly dependent upon the material which forms the access device 34. In a preferred embodiment, the pad 35 is formed of a KRATON/oil mixture including a KRATON Tri-block with a Styrene-Ethylene/Butylene-Styrene (S-E/B-S) structure in combination with a mineral oil. Other tri-block polymers can be used for this application such as Styrene-Isoprene-Styrene, (S-I-S), Styrene-Butadiene-Styrene (S-B-S), Styrene-Ethylene/Propylene-Styrene (S-E/P-S) manufactured under the trademark SEPTON by the Kuraray Co. These general formulas can be further distinguished by the ratio of the styrene to rubber content: for example, Grade 1650 is a S-E/B-S tri-block with a 29/71 styrene to rubber ratio.
In addition to tri-blocks there are also di-block versions of these materials where styrene is present at only one end of the formula, for example, Styrene-Ethylene/Butylene (S-E/B) di-block.
The various base formulas may also be alloyed with one another to achieve a variety of intermediate properties. For example KRATON G1701X is a 70% S-E/B 30% S-E/B-S mixture with an overall Styrene to rubber ratio of 28/72. It can be appreciated that an almost infinite number of combinations, alloys, and Styrene to rubber ratios can be formulated, each capable of providing advantages to a particular embodiment of the invention. These advantages will typically include low durometer, high elongation, and good tear strength.
It is contemplated that the material of the pad 35 may also include silicone, soft urethanes and even harder plastics which might provide the desired sealing qualities with the addition of a foaming agent. The silicone materials can be of the types currently used for electronic encapsulation. The harder plastics may include PVC, Isoprene, KRATON neat, and other KRATON/oil mixtures. In the KRATON/oil mixture, for example, oils such as vegetable oils, petroleum oils and silicone oils might be substituted for the mineral oil. In the broadest sense, all of these mixtures can be described generally as a gel. The gel will typically have properties including an ability to “flow” which approaches that of a fluid. Particularly in the vicinity of any opening or slit 45 extending through the access device 34, propagation of the opening may be of concern. Stresses resulting from the presence of an instrument will be concentrated at the ends of such an opening or slit. For this reason, a good tear resistance is desired for the gel material. Such a tear resistance is often inherent in the KRATON/oil mixtures and may be enhanced by encapsulating the gel in other materials. For example, a low tear resistant gel could be encapsulated in a urethane sheath to improve the tear resistant qualities of the resulting products. Such a sheath need not be elastic but could be comprised, for example, of overlapping sheets of a non-elastic material.
Any of the gel materials contemplated could be modified to achieve different properties such as enhanced lubricity, appearance, and wound protection, or to provide anti-cancer or anti-microbial activity. Additives can be incorporated directly into the gel, for example in the case of pharmaceuticals, or applied as a surface treatment to the gel, for example, to improve lubricity or appearance. Other compounds could be added to the gel to modify its physical properties or to assist in subsequent modification of the surface by providing bonding sites or a surface charge. Antioxidants and antirads can be added to the mixture to extend the shelf life of the finished product or increase its ability to withstand radiation sterilization.
Sealing materials used in medical access devices of the past have been chosen primarily for their durometer and elongation. It is these properties which measure the ability of the material to move into small spaces and crevices as may be required to form an instrument seal across the working channel of a trocar. For example, in the past, a silicone mixture was used in medical valves. This mixture had the following properties: an ultimate elongation less than about 1000 percent and a durometer not less than about 5 Shore A.
These properties of the prior art materials are far exceeded by the properties associated with the present invention which in some respects provide a full magnitude of advantage. In fact, the difference between the materials of the prior art and the materials of the present invention are sufficiently substantial, that it is perhaps misleading to refer to the present material as merely a gel. According, the material of the present invention, having properties including an ultimate elongation greater than about 1000 percent and a durometer less than about 5 Shore A, will be referred to herein as an “ultragel.”
In a preferred embodiment of the present invention, the ultragel includes KRATON and mineral oil and provides a sealing material with the following properties: an ultimate elongation exceeding about 1500 percent, and a durometer of less than about 200 Bloom. The durometer in this case is considerably lower than that of the prior art materials. In fact, the durometer of the present material is so soft it cannot even be measured on the Shore A scale.
The resulting elongation and durometer of the present material facilitates its use with as an access valve which is capable of forming seals with a full range of instrument sizes, but is also capable of functioning as a zero seal. Whereas access devices of the prior art may have required as many as six separate seals in order to accommodate a full range of instrument sizes, access devices can now be made with only a single valve formed of the ultragel material.
In a typical manufacturing process, the KRATON G1651 is mixed with the mineral oil in a ratio by weight of 1 to 9. In order to manufacture this material, the combination is heated to a temperature of about 200° centigrade. In a preferred method of manufacturing, the mold is provided with a circumferential ring insert which is molded into the gel, and slit inserts which can be removed from the gel to form the opening or slit 45. The resulting gel can be coated with cornstarch to reduce tack and cooled at room temperature.
Many of the properties of the KRATON/oil mixture will vary with adjustments in the weight ratio of the components. In general, the greater the percentage of mineral oil, the more fluid the mixture; the greater the percentage of KRATON, the more rigid the material. Weight ratios of KRATON to oil as low as 1 to 5 have been contemplated for a more rigid structure. As the KRATON/oil weight ratio approaches 1 to 10, the mixture becomes more liquid. Ratios as high as 1 to 15 have been contemplated for this invention.
The processing temperature can also vary considerably as it is primarily dependent on the type of KRATON used. Temperatures in a range of about 150° centigrade to about 250° centigrade have been contemplated.
With an appreciation that these ratios and temperatures can develop considerably different properties, it is now apparent that these materials can be layered to provide generally different properties within each layer. For example, an outer layer might be formed of a KRATON/oil mixture having more rigid properties, thereby providing the pad 35 with an outer layer that is more rigid. After that layer is at least partially cured, another layer of the material can be poured inside of the outer layer. This second layer might be softer providing the pad 35 with the significant sealing properties. It has been found that successive layers will tend to fuse slightly at their interface, but will generally maintain their separate identities. Additional layers could be added to provide a progression of properties in a particular device.
Having discussed the properties desirable for the gel material, and the process of manufacture, one can now address the other embodiments of the concept which may provide additional advantages for particular surgical procedures. An embodiment of the access device 34, shown in its operative position in
This same embodiment can be reinforced with o-rings 61 and 63 as illustrated in
A further embodiment of the invention is illustrated in
When the embodiment of
In this particular embodiment, the pad 35c functions generally as described with reference to
This embodiment of
A further embodiment of the invention is illustrated in
In a preferred embodiment, this cavity 70 is sized and configured to receive the arm 16 of the surgeon 14 in a manner illustrated in
A further embodiment of the invention is illustrated in the plan view of
As perhaps best illustrated in
A further embodiment of the invention is illustrated in
The duck-bill valve 72 can be formed with opposing flanges 76 and 78 which extend distally of the distal surface 73. When operatively disposed, the pad 35f can be positioned with its distal surface 73 against the exterior surface of the abdominal wall 21 (
A further embodiment of the invention is illustrated in
Another simplified form of the invention is illustrated in
It will be appreciated generally, that the slit 45 and lead-in cavity 70 can be provided with many different individual and cooperative configurations. By way of example, perhaps the simplest form for the pad 35 is illustrated in the embodiment of
The slit 45j in this embodiment of
It will be apparent that the slit 45 need not be formed by opposing surfaces having a planar configuration. Nevertheless, these opposing surfaces need to be capable of coming into sealing contact with each other in order to establish the zero seal. Other slit configurations capable of accomplishing this function, may offer further advantages in particular procedures. Other examples of slit configurations are illustrated merely by way of example in
The embodiment of
In the embodiment of
In the embodiment of
In an embodiment where the channel 100 is left open, a zero seal might be provided by positioning a septum valve across the channel 100. Such an embodiment is illustrated in
Other curved slit configurations would include embodiments wherein the slit is curved, sinusoidal, or S-shaped in a side elevation view. Such configurations provide a slit part having a length greater than the thickness of the pad. Normally, the more circuitous the slit path, the better the sealing characteristics.
A further and more complex configuration for the opening 45 is illustrated in the embodiment of
In this construction, the base 110 is provided with a plurality of spokes 114 each of which extends radially inwardly from a base 116 to a tip 118. The core 112 extends from the axis 47q outwardly to the tips 118 of the spokes 114. In the illustrated embodiment, the core 112 has fingers 121 which extend beyond the tips 118 and toward the bases 116 between each adjacent pair of the spokes 114. These fingers 121 extend radially outwardly to an end surface 123 which stops short of the base 116 leaving a void 125 therebetween.
The voids 125 are of particular interest to this embodiment and can be incorporated into any of the embodiments previously discussed. Such voids 125 provide a space or absence of material into which the highly elastic material, such as that of the fingers 121, can expand during insertion of an instrument such as the arm 16 (
In the case of
A further embodiment of the invention is illustrated in
The gel cap 143 includes not only the gel pad 35s, but also a circumferential cap ring 154 which can be inserted and molded to the pad 35s. The resulting gel cap 143 forms a seal with the base 145, thereby defining the working channel 36s through the pad 35s, the cap ring 154, the base 145, and the retraction sheath 147. In the manner previously discussed, this working channel 36s includes the single valve formed by the gel pad 35s which provides both a zero seal and an instrument seal for a wide range of instrument diameters.
The structure associated with the gel cap 143 is described in greater detail with reference to
The gel pad 35s can be formed of any of the materials previously discussed although the preferred embodiment includes the KRATON/mineral oil gel. The cap ring 154 for such an embodiment can be advantageously formed of KRATON only. This will make the cap ring 154 more rigid than the gel pad 35s while maintaining an excellent material interface between the pad 35s and the ring 154. In a typical manufacturing operation, the cap ring will be pre-disposed in the mold for the gel pad 35s with the unitary structure of the gel cap 143 resulting.
The cross section view of
The base 145 of this embodiment is shown in greater detail in the plan and cross section of views of
Distally of the inner surface 163, an annular flange 170 can be provided with an annular projection 172 sized and configured to form the desired sealing relationship between the gel cap 143 and the base 145. The process of molding the base 145 can be facilitated by forming the base as two separate components divided, for example, by a dotted line 174 in
A preferred embodiment of the retracting sheath 147 is illustrated in
As the sheath 147 is stretched axially, the diameter of the cylindrical proximal end increases thereby placing radial forces on the incision 32. The more the sheath 147 is stretched axially, the greater becomes the diameter of the sheath and consequently the larger becomes the opening through the incision 32. This feature is of particular advantage as it permits the surgeon to define the size of the incision 32 with an appropriate degree of axial tension on the sheath 147. By maintaining this tension, the preferred size of the incision 132 is maintained throughout the operation. In a preferred apparatus and method, the axial tension is maintained by stretching the sheath 147 over the tabs 167 (
The fold 153 is provided to facilitate a grip on the proximal end of the sheath 147. This fold 153 can also function to provide reinforcement where the walls of the sheath 147 engage the tabs 167 of the base 145. In the embodiment illustrated in
The method of using the embodiment of
As illustrated in
Prior to or after inserting the sheath 147, the base 145 can be disposed around the incision 32. Then the exposed portions of the sheath 147 will extend through the incision 32 and within the circumferential base 145. As illustrated in
When the incision 32 has the desired size, the stretched sheath 147 can be drawn over the tabs 167 to maintain the axial stretch and the desired size for the incision 32. Either the indicia 182, as shown in
A final step remaining in this process is the attachment of the gel cap 143 to the base 145. This is accomplished as illustrated in
Although this invention has been disclosed with reference to certain structural configurations, it will be appreciated that these products are merely representative of many different embodiments of the invention. Accordingly, one is cautioned not to limit the concept only to the disclosed embodiments, but rather encouraged to determine the scope of the invention only with reference to the following claims.
This application is a continuation of U.S. application Ser. No. 12/360,710, filed Jan. 27, 2009, which is a continuation of U.S. application Ser. No. 11/244,647, filed Oct. 5, 2005, now U.S. Pat. No. 7,481,765, which is a continuation of U.S. application Ser. No. 10/381,220, filed Mar. 20, 2003, now U.S. Pat. No. 7,473,221, which is the National Phase application under 35 U.S.C. §371 of International Application No. PCT/US2001/029682, filed Sep. 21, 2001, which published in English as International Publication No. WO 2002/034108 A1 on May 2, 2002, which claims the benefit of U.S. Application No. 60/241,958, filed Oct. 19, 2000, all of the disclosures of which are incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
558364 | Doolittle | Apr 1896 | A |
1157202 | Bates et al. | Oct 1915 | A |
1598284 | Kinney | Aug 1926 | A |
1690995 | Pratt | Nov 1928 | A |
1180466 | Deutsch | Jun 1931 | A |
1810466 | Deutsch | Jun 1931 | A |
2219564 | Reyniers | Oct 1940 | A |
2305289 | Coburg | Dec 1942 | A |
2478586 | Krapp | Aug 1949 | A |
2669991 | Curutchet | Feb 1954 | A |
2695608 | Gibbon | Nov 1954 | A |
2812758 | Blumenschein | Nov 1957 | A |
2835253 | Borgeson | May 1958 | A |
2853075 | Hoffman et al. | Sep 1958 | A |
3039468 | Price | Jun 1962 | A |
3057350 | Cowley | Oct 1962 | A |
3111943 | Orndorff | Nov 1963 | A |
3195934 | Parrish | Jul 1965 | A |
3244169 | Baxter | Apr 1966 | A |
3253594 | Matthews et al. | May 1966 | A |
3313299 | Spademan | Apr 1967 | A |
3329390 | Hulsey | Jul 1967 | A |
3332417 | Blanford et al. | Jul 1967 | A |
3347226 | Harrower | Oct 1967 | A |
3347227 | Harrower | Oct 1967 | A |
3397692 | Creager, Jr. et al. | Aug 1968 | A |
3402710 | Paleschuck | Sep 1968 | A |
3416520 | Creager, Jr. | Dec 1968 | A |
3447533 | Spicer | Jun 1969 | A |
3522800 | Lesser | Aug 1970 | A |
3523534 | Nolan | Aug 1970 | A |
3570475 | Weinstein | Mar 1971 | A |
3656485 | Robertson | Apr 1972 | A |
3685786 | Woodson | Aug 1972 | A |
3717151 | Collett | Feb 1973 | A |
3717883 | Mosher | Feb 1973 | A |
3729006 | Wilder et al. | Apr 1973 | A |
3782370 | McDonald | Jan 1974 | A |
3797478 | Walsh et al. | Mar 1974 | A |
3799166 | Marsan | Mar 1974 | A |
3807393 | McDonald | Apr 1974 | A |
3828764 | Jones | Aug 1974 | A |
3831583 | Edmunds et al. | Aug 1974 | A |
3841332 | Treacle | Oct 1974 | A |
3850172 | Cazalis | Nov 1974 | A |
3853126 | Schulte | Dec 1974 | A |
3853127 | Spademan | Dec 1974 | A |
3856021 | McIntosh | Dec 1974 | A |
3860274 | Ledstrom et al. | Jan 1975 | A |
3861416 | Wichterle | Jan 1975 | A |
3907389 | Cox et al. | Sep 1975 | A |
3915171 | Shermeta | Oct 1975 | A |
3965890 | Gauthier | Jun 1976 | A |
3970089 | Saice | Jul 1976 | A |
3996623 | Kaster | Dec 1976 | A |
4000739 | Stevens | Jan 1977 | A |
4016884 | Kwan-Gett | Apr 1977 | A |
4024872 | Muldoon | May 1977 | A |
4030500 | Ronnquist | Jun 1977 | A |
4043328 | Cawood, Jr. et al. | Aug 1977 | A |
4069913 | Harrigan | Jan 1978 | A |
4082005 | Erdley | Apr 1978 | A |
4083370 | Taylor | Apr 1978 | A |
4096853 | Weigand | Jun 1978 | A |
4112932 | Chiulli | Sep 1978 | A |
4130113 | Graham | Dec 1978 | A |
4177814 | Knepshield et al. | Dec 1979 | A |
4183357 | Bentley et al. | Jan 1980 | A |
4187849 | Stim | Feb 1980 | A |
4188945 | Wenander | Feb 1980 | A |
4217664 | Faso | Aug 1980 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4228792 | Rhys-Davies | Oct 1980 | A |
4239036 | Krieger | Dec 1980 | A |
4240411 | Hosono | Dec 1980 | A |
4253201 | Ross et al. | Mar 1981 | A |
4254973 | Benjamin | Mar 1981 | A |
4306562 | Osborne | Dec 1981 | A |
4321915 | Leighton | Mar 1982 | A |
4331138 | Jessen | May 1982 | A |
4338934 | Spademan | Jul 1982 | A |
4338937 | Lerman | Jul 1982 | A |
4367728 | Mutke | Jan 1983 | A |
4369284 | Chen | Jan 1983 | A |
4399816 | Spangler | Aug 1983 | A |
4402683 | Kopman | Sep 1983 | A |
4411659 | Jensen et al. | Oct 1983 | A |
4421296 | Stephens | Dec 1983 | A |
4424833 | Spector et al. | Jan 1984 | A |
4428364 | Bartolo | Jan 1984 | A |
4430081 | Timmermans | Feb 1984 | A |
4434791 | Darnell | Mar 1984 | A |
4436519 | O'Neill | Mar 1984 | A |
4454873 | Laufenberg et al. | Jun 1984 | A |
4473067 | Schiff | Sep 1984 | A |
4475548 | Muto | Oct 1984 | A |
4485490 | Akers et al. | Dec 1984 | A |
4488877 | Klein | Dec 1984 | A |
4543088 | Bootman et al. | Sep 1985 | A |
4550713 | Hyman | Nov 1985 | A |
4553537 | Rosenberg | Nov 1985 | A |
4555242 | Saudagar | Nov 1985 | A |
4556996 | Wallace | Dec 1985 | A |
4601710 | Moll | Jul 1986 | A |
4610665 | Matsumoto et al. | Sep 1986 | A |
4626245 | Weinstein | Dec 1986 | A |
4634424 | O'Boyle | Jan 1987 | A |
4634432 | Kocak | Jan 1987 | A |
4644951 | Bays | Feb 1987 | A |
4649904 | Krauter | Mar 1987 | A |
4653476 | Bonnet | Mar 1987 | A |
4654030 | Moll et al. | Mar 1987 | A |
4655752 | Honkanen et al. | Apr 1987 | A |
4673393 | Suzuki et al. | Jun 1987 | A |
4673394 | Fenton | Jun 1987 | A |
4691942 | Ford | Sep 1987 | A |
4714749 | Hughes et al. | Dec 1987 | A |
4738666 | Fuqua | Apr 1988 | A |
4755170 | Golden | Jul 1988 | A |
4760933 | Christner et al. | Aug 1988 | A |
4776843 | Martinez et al. | Oct 1988 | A |
4777943 | Chvapil | Oct 1988 | A |
4784646 | Feingold | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4798594 | Hillstead | Jan 1989 | A |
4802694 | Vargo | Feb 1989 | A |
4808168 | Warring | Feb 1989 | A |
4809679 | Shimonaka et al. | Mar 1989 | A |
4828554 | Griffin | May 1989 | A |
4842931 | Zook | Jun 1989 | A |
4848575 | Nakamura et al. | Jul 1989 | A |
4856502 | Ersfeld et al. | Aug 1989 | A |
4863430 | Klyce et al. | Sep 1989 | A |
4863438 | Gauderer et al. | Sep 1989 | A |
4889107 | Kaufman | Dec 1989 | A |
4895565 | Hillstead | Jan 1990 | A |
4897081 | Poirier | Jan 1990 | A |
4903710 | Jessamine et al. | Feb 1990 | A |
4911974 | Shimizu et al. | Mar 1990 | A |
4915132 | Hodge et al. | Apr 1990 | A |
4926882 | Lawrence | May 1990 | A |
4929235 | Merry et al. | May 1990 | A |
4944732 | Russo | Jul 1990 | A |
4950222 | Scott et al. | Aug 1990 | A |
4950223 | Silvanov | Aug 1990 | A |
4984564 | Yuen | Jan 1991 | A |
4991593 | LeVahn | Feb 1991 | A |
4998538 | Charowsky et al. | Mar 1991 | A |
5000745 | Guest et al. | Mar 1991 | A |
5009224 | Cole | Apr 1991 | A |
5015228 | Columbus et al. | May 1991 | A |
5019101 | Purkait et al. | May 1991 | A |
5026366 | Leckrone | Jun 1991 | A |
5037379 | Clayman et al. | Aug 1991 | A |
5041095 | Littrell | Aug 1991 | A |
5045070 | Grodecki et al. | Sep 1991 | A |
D320658 | Quigley et al. | Oct 1991 | S |
5071411 | Hillstead | Dec 1991 | A |
5073169 | Raiken | Dec 1991 | A |
5074878 | Bark et al. | Dec 1991 | A |
5082005 | Kaldany | Jan 1992 | A |
5086763 | Hathman | Feb 1992 | A |
5092846 | Nishijima et al. | Mar 1992 | A |
5104389 | Deem | Apr 1992 | A |
5125396 | Ray | Jun 1992 | A |
5125897 | Quinn et al. | Jun 1992 | A |
5127626 | Hilal et al. | Jul 1992 | A |
5129885 | Green et al. | Jul 1992 | A |
5141498 | Christian | Aug 1992 | A |
5149327 | Oshiyama | Sep 1992 | A |
5156617 | Reid | Oct 1992 | A |
5158553 | Berry et al. | Oct 1992 | A |
5159921 | Hoover | Nov 1992 | A |
5161773 | Tower | Nov 1992 | A |
5167636 | Clement | Dec 1992 | A |
5167637 | Okada et al. | Dec 1992 | A |
5176648 | Holmes et al. | Jan 1993 | A |
5176662 | Bartholomew et al. | Jan 1993 | A |
5176697 | Hasson et al. | Jan 1993 | A |
5178162 | Bose | Jan 1993 | A |
5180365 | Ensminger et al. | Jan 1993 | A |
5183471 | Wilk | Feb 1993 | A |
5188595 | Jacobi | Feb 1993 | A |
5188607 | Wu | Feb 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5197955 | Stephens et al. | Mar 1993 | A |
5207656 | Kranys | May 1993 | A |
5209737 | Rirchart et al. | May 1993 | A |
5211370 | Powers | May 1993 | A |
5211633 | Stouder, Jr. | May 1993 | A |
5213114 | Bailey, Jr. | May 1993 | A |
5226890 | Ianniruberto et al. | Jul 1993 | A |
5234455 | Mulhollan | Aug 1993 | A |
5241968 | Slater | Sep 1993 | A |
5242400 | Blake et al. | Sep 1993 | A |
5242409 | Buelna | Sep 1993 | A |
5242412 | Blake, III | Sep 1993 | A |
5242415 | Kantrowitz et al. | Sep 1993 | A |
5248304 | Vigdorchik et al. | Sep 1993 | A |
5256150 | Quiachon et al. | Oct 1993 | A |
5257973 | Villasuso | Nov 1993 | A |
5257975 | Foshee | Nov 1993 | A |
5259366 | Reydel et al. | Nov 1993 | A |
5261883 | Hood et al. | Nov 1993 | A |
5262468 | Chen | Nov 1993 | A |
5263922 | Sova et al. | Nov 1993 | A |
5269763 | Boehmer et al. | Dec 1993 | A |
5269772 | Wilk | Dec 1993 | A |
5273449 | Mattis et al. | Dec 1993 | A |
5273545 | Hunt et al. | Dec 1993 | A |
D343236 | Quigley et al. | Jan 1994 | S |
5279575 | Sugarbaker | Jan 1994 | A |
5290310 | Makower et al. | Mar 1994 | A |
D346022 | Quigley et al. | Apr 1994 | S |
5299582 | Potts | Apr 1994 | A |
5300034 | Behnke | Apr 1994 | A |
5300035 | Clement | Apr 1994 | A |
5300036 | Mueller et al. | Apr 1994 | A |
5308336 | Hart et al. | May 1994 | A |
5309896 | Moll et al. | May 1994 | A |
5312391 | Wilk | May 1994 | A |
5314417 | Stephens et al. | May 1994 | A |
5316541 | Fischer | May 1994 | A |
5320611 | Bonutti et al. | Jun 1994 | A |
5330437 | Durman | Jul 1994 | A |
5330486 | Wilk | Jul 1994 | A |
5330497 | Freitas et al. | Jul 1994 | A |
5331975 | Bonutti | Jul 1994 | A |
5334143 | Carroll | Aug 1994 | A |
5334646 | Chen | Aug 1994 | A |
5336192 | Palestrant | Aug 1994 | A |
5336708 | Chen | Aug 1994 | A |
5338313 | Mollenauer et al. | Aug 1994 | A |
5342315 | Rowe et al. | Aug 1994 | A |
5342385 | Norelli et al. | Aug 1994 | A |
5350364 | Stephens et al. | Sep 1994 | A |
5353786 | Wilk | Oct 1994 | A |
5354280 | Haber et al. | Oct 1994 | A |
5360417 | Gravener et al. | Nov 1994 | A |
5364345 | Lowery et al. | Nov 1994 | A |
5364372 | Danks et al. | Nov 1994 | A |
5366446 | Tal et al. | Nov 1994 | A |
5366478 | Brinkerhoff et al. | Nov 1994 | A |
5368545 | Schaller et al. | Nov 1994 | A |
5375588 | Yoon | Dec 1994 | A |
5380288 | Hart et al. | Jan 1995 | A |
5383861 | Hempel et al. | Jan 1995 | A |
5385552 | Haber et al. | Jan 1995 | A |
5385553 | Hart et al. | Jan 1995 | A |
5385560 | Wulf | Jan 1995 | A |
5389080 | Yoon | Feb 1995 | A |
5389081 | Castro | Feb 1995 | A |
5391153 | Haber et al. | Feb 1995 | A |
5391156 | Hildwein et al. | Feb 1995 | A |
5395367 | Wilk | Mar 1995 | A |
5403264 | Wohlers et al. | Apr 1995 | A |
5403336 | Kieturakis et al. | Apr 1995 | A |
5407433 | Loomas | Apr 1995 | A |
5411483 | Loomas | May 1995 | A |
5413571 | Katsaros et al. | May 1995 | A |
5423848 | Washizuka et al. | Jun 1995 | A |
5429609 | Yoon | Jul 1995 | A |
5431676 | Durdal et al. | Jul 1995 | A |
5437683 | Neumann et al. | Aug 1995 | A |
5439455 | Kieturakis et al. | Aug 1995 | A |
5441486 | Yoon | Aug 1995 | A |
5443452 | Hart et al. | Aug 1995 | A |
5456284 | Ryan et al. | Oct 1995 | A |
5460170 | Hammerslag | Oct 1995 | A |
5460616 | Weinstein et al. | Oct 1995 | A |
5468248 | Chin et al. | Nov 1995 | A |
5476475 | Gadberry | Dec 1995 | A |
5480410 | Cuschieri et al. | Jan 1996 | A |
5486426 | McGee et al. | Jan 1996 | A |
5490843 | Hildwein et al. | Feb 1996 | A |
5492304 | Smith et al. | Feb 1996 | A |
5496280 | Vandenbroek et al. | Mar 1996 | A |
5503112 | Luhman et al. | Apr 1996 | A |
5507758 | Thomason et al. | Apr 1996 | A |
5508334 | Chen | Apr 1996 | A |
5511564 | Wilk | Apr 1996 | A |
5514109 | Mollenauer et al. | May 1996 | A |
5514133 | Golub et al. | May 1996 | A |
5514153 | Bonutti | May 1996 | A |
5518278 | Sampson | May 1996 | A |
5520632 | Leveen | May 1996 | A |
5522791 | Leyva | Jun 1996 | A |
5522824 | Ashby | Jun 1996 | A |
5524644 | Crook | Jun 1996 | A |
5526536 | Cartmill | Jun 1996 | A |
5531758 | Uschold et al. | Jul 1996 | A |
5538509 | Dunlap et al. | Jul 1996 | A |
5540648 | Yoon | Jul 1996 | A |
5540711 | Kieturakis et al. | Jul 1996 | A |
5545150 | Danks et al. | Aug 1996 | A |
5545179 | Williamson, IV | Aug 1996 | A |
5549563 | Kronner | Aug 1996 | A |
5549637 | Crainich | Aug 1996 | A |
5554124 | Alvarado | Sep 1996 | A |
5562632 | Davila et al. | Oct 1996 | A |
5562677 | Hildwein et al. | Oct 1996 | A |
5562688 | Riza | Oct 1996 | A |
5571115 | Nicholas | Nov 1996 | A |
5571137 | Marlow et al. | Nov 1996 | A |
5575799 | Bolanos et al. | Nov 1996 | A |
5577993 | Zhu et al. | Nov 1996 | A |
5578048 | Pasqualucci et al. | Nov 1996 | A |
5580344 | Hasson | Dec 1996 | A |
5584850 | Hart et al. | Dec 1996 | A |
5601579 | Semertzides | Feb 1997 | A |
5601581 | Fogarty et al. | Feb 1997 | A |
5603702 | Smith et al. | Feb 1997 | A |
5607443 | Kieturakis et al. | Mar 1997 | A |
5620415 | Lucey et al. | Apr 1997 | A |
5620420 | Kriesel | Apr 1997 | A |
5628732 | Antoon, Jr. et al. | May 1997 | A |
5632284 | Graether | May 1997 | A |
5632979 | Goldberg et al. | May 1997 | A |
5634911 | Hermann et al. | Jun 1997 | A |
5634936 | Linden et al. | Jun 1997 | A |
5634937 | Mollenauer et al. | Jun 1997 | A |
5636645 | Ou | Jun 1997 | A |
5640977 | Leahy et al. | Jun 1997 | A |
5643301 | Mollenauer | Jul 1997 | A |
5649550 | Crook | Jul 1997 | A |
5651771 | Tangherlini et al. | Jul 1997 | A |
5653705 | de la Torre et al. | Aug 1997 | A |
5657963 | Hinchliffe et al. | Aug 1997 | A |
5658272 | Hasson | Aug 1997 | A |
5658306 | Kieturakis | Aug 1997 | A |
5662615 | Blake, III | Sep 1997 | A |
5672168 | de la Torre et al. | Sep 1997 | A |
5681341 | Lunsford et al. | Oct 1997 | A |
5683378 | Christy | Nov 1997 | A |
5685854 | Green et al. | Nov 1997 | A |
5685857 | Negus et al. | Nov 1997 | A |
5697914 | Brimhall | Dec 1997 | A |
5707703 | Rothrum et al. | Jan 1998 | A |
5709664 | Vandenbroek et al. | Jan 1998 | A |
5713858 | Heruth et al. | Feb 1998 | A |
5713869 | Morejon | Feb 1998 | A |
5720730 | Blake, III | Feb 1998 | A |
5725536 | Oberlin et al. | Mar 1998 | A |
5728103 | Picha et al. | Mar 1998 | A |
5730748 | Fogarty et al. | Mar 1998 | A |
5735791 | Alexander et al. | Apr 1998 | A |
5738628 | Sierocuk et al. | Apr 1998 | A |
5741234 | Aboul-Hosn | Apr 1998 | A |
5741298 | MacLeod | Apr 1998 | A |
5743884 | Hasson et al. | Apr 1998 | A |
5749882 | Hart et al. | May 1998 | A |
5755660 | Tyagi | May 1998 | A |
5760117 | Chen | Jun 1998 | A |
5769783 | Fowler | Jun 1998 | A |
5782812 | Hart et al. | Jul 1998 | A |
5782817 | Franzel et al. | Jul 1998 | A |
5782859 | Nicholas et al. | Jul 1998 | A |
5788676 | Yoon | Aug 1998 | A |
5792119 | Marx | Aug 1998 | A |
5795290 | Bridges | Aug 1998 | A |
5803919 | Hart et al. | Sep 1998 | A |
5803921 | Bonadio | Sep 1998 | A |
5803923 | Singh-Derewa et al. | Sep 1998 | A |
5807350 | Diaz | Sep 1998 | A |
5810712 | Dunn | Sep 1998 | A |
5810721 | Mueller et al. | Sep 1998 | A |
5813409 | Leahy et al. | Sep 1998 | A |
5814026 | Yoon | Sep 1998 | A |
5817062 | Flom et al. | Oct 1998 | A |
5819375 | Kastner | Oct 1998 | A |
5820555 | Watkins, III et al. | Oct 1998 | A |
5820600 | Carlson et al. | Oct 1998 | A |
5830191 | Hildwein et al. | Nov 1998 | A |
5832925 | Rothrum | Nov 1998 | A |
5836871 | Wallace et al. | Nov 1998 | A |
5841298 | Huang | Nov 1998 | A |
5842971 | Yoon | Dec 1998 | A |
5848992 | Hart et al. | Dec 1998 | A |
5853395 | Crook et al. | Dec 1998 | A |
5853417 | Fogarty et al. | Dec 1998 | A |
5857461 | Levitsky et al. | Jan 1999 | A |
5860995 | Berkelaar | Jan 1999 | A |
5865728 | Moll et al. | Feb 1999 | A |
5865729 | Meehan et al. | Feb 1999 | A |
5865807 | Blake, III | Feb 1999 | A |
5865817 | Moenning et al. | Feb 1999 | A |
5871474 | Hermann et al. | Feb 1999 | A |
5876413 | Fogarty et al. | Mar 1999 | A |
5879368 | Hoskin et al. | Mar 1999 | A |
5882344 | Strouder, Jr. | Mar 1999 | A |
5884639 | Chen | Mar 1999 | A |
5894843 | Benetti et al. | Apr 1999 | A |
5895377 | Smith et al. | Apr 1999 | A |
5899208 | Bonadio | May 1999 | A |
5899913 | Fogarty et al. | May 1999 | A |
5904703 | Gilson | May 1999 | A |
5906577 | Beane et al. | May 1999 | A |
5913847 | Yoon | Jun 1999 | A |
5916198 | Dillow | Jun 1999 | A |
5916232 | Hart | Jun 1999 | A |
5919476 | Fischer et al. | Jul 1999 | A |
5931832 | Jensen | Aug 1999 | A |
5947922 | MacLeod | Sep 1999 | A |
5951467 | Picha et al. | Sep 1999 | A |
5951588 | Moenning | Sep 1999 | A |
5957888 | Hinchiffe et al. | Sep 1999 | A |
5957913 | de la Torre et al. | Sep 1999 | A |
5962572 | Chen | Oct 1999 | A |
5964781 | Mollenauer et al. | Oct 1999 | A |
5976174 | Ruiz | Nov 1999 | A |
5989232 | Yoon | Nov 1999 | A |
5989233 | Yoon | Nov 1999 | A |
5989266 | Foster | Nov 1999 | A |
5993471 | Riza et al. | Nov 1999 | A |
5993485 | Beckers | Nov 1999 | A |
5994450 | Pearce | Nov 1999 | A |
5997515 | de la Torre et al. | Dec 1999 | A |
6004303 | Peterson | Dec 1999 | A |
6010494 | Schafer et al. | Jan 2000 | A |
6017355 | Hessel et al. | Jan 2000 | A |
6018094 | Fox | Jan 2000 | A |
6024736 | de la Torre et al. | Feb 2000 | A |
6025067 | Fay | Feb 2000 | A |
6033426 | Kaji | Mar 2000 | A |
6033428 | Sardella | Mar 2000 | A |
6035559 | Freed et al. | Mar 2000 | A |
6042573 | Lucey | Mar 2000 | A |
6045535 | Ben Nun | Apr 2000 | A |
6048309 | Flom et al. | Apr 2000 | A |
6050871 | Chen | Apr 2000 | A |
6053934 | Andrews et al. | Apr 2000 | A |
6059816 | Moenning | May 2000 | A |
6066117 | Fox et al. | May 2000 | A |
6068639 | Fogarty et al. | May 2000 | A |
6077288 | Shimomura | Jun 2000 | A |
6086603 | Termin et al. | Jul 2000 | A |
6090043 | Austin et al. | Jul 2000 | A |
6099506 | Macoviak et al. | Aug 2000 | A |
6110154 | Shimomura et al. | Aug 2000 | A |
6123689 | To | Sep 2000 | A |
6142935 | Flom et al. | Nov 2000 | A |
6142936 | Beane et al. | Nov 2000 | A |
6149642 | Gerhart et al. | Nov 2000 | A |
6150608 | Wambeke et al. | Nov 2000 | A |
6159182 | Davis | Dec 2000 | A |
6162172 | Cosgrove et al. | Dec 2000 | A |
6162196 | Hart et al. | Dec 2000 | A |
6162206 | Bindokas | Dec 2000 | A |
6163949 | Neuenschwander | Dec 2000 | A |
6164279 | Tweedle | Dec 2000 | A |
6171282 | Ragsdale | Jan 2001 | B1 |
6183486 | Snow et al. | Feb 2001 | B1 |
6197002 | Peterson | Mar 2001 | B1 |
6217555 | Hart et al. | Apr 2001 | B1 |
6217590 | Levinson | Apr 2001 | B1 |
6224612 | Bates et al. | May 2001 | B1 |
6228063 | Aboul-Hosn | May 2001 | B1 |
6238373 | de la Torre et al. | May 2001 | B1 |
6241768 | Agarwal et al. | Jun 2001 | B1 |
6254533 | Fadem et al. | Jul 2001 | B1 |
6254534 | Butler et al. | Jul 2001 | B1 |
6258065 | Dennis et al. | Jul 2001 | B1 |
6264604 | Kieturakis et al. | Jul 2001 | B1 |
6267751 | Mangosong | Jul 2001 | B1 |
6276661 | Laird | Aug 2001 | B1 |
6287280 | Lampropoulos et al. | Sep 2001 | B1 |
6315770 | de la Torre et al. | Nov 2001 | B1 |
6319246 | de la Torre et al. | Nov 2001 | B1 |
6322541 | West | Nov 2001 | B2 |
6325384 | Berry, Sr. et al. | Dec 2001 | B1 |
6346074 | Roth | Feb 2002 | B1 |
6371968 | Kogasaka et al. | Apr 2002 | B1 |
6382211 | Crook | May 2002 | B1 |
6383162 | Sugarbaker | May 2002 | B1 |
6391043 | Moll et al. | May 2002 | B1 |
6413244 | Bestetti et al. | Jul 2002 | B1 |
6413458 | Pearce | Jul 2002 | B1 |
6420475 | Chen | Jul 2002 | B1 |
6423036 | Van Huizen | Jul 2002 | B1 |
6440061 | Wenner et al. | Aug 2002 | B1 |
6440063 | Beane et al. | Aug 2002 | B1 |
6443957 | Addis | Sep 2002 | B1 |
6447489 | Peterson | Sep 2002 | B1 |
6450983 | Rambo | Sep 2002 | B1 |
6454783 | Piskun | Sep 2002 | B1 |
6464686 | O'Hara et al. | Oct 2002 | B1 |
6468292 | Mollenauer et al. | Oct 2002 | B1 |
6482181 | Racenet et al. | Nov 2002 | B1 |
6485435 | Bakal | Nov 2002 | B1 |
6485467 | Crook et al. | Nov 2002 | B1 |
6488620 | Segermark et al. | Dec 2002 | B1 |
6488692 | Spence et al. | Dec 2002 | B1 |
6494893 | Dubrul et al. | Dec 2002 | B2 |
6527787 | Fogarty et al. | Mar 2003 | B1 |
6533734 | Corley, III et al. | Mar 2003 | B1 |
6551270 | Bimbo et al. | Apr 2003 | B1 |
6551276 | Mann et al. | Apr 2003 | B1 |
6551344 | Thill | Apr 2003 | B2 |
6552109 | Chen | Apr 2003 | B1 |
6554793 | Pauker et al. | Apr 2003 | B1 |
6558371 | Dorn | May 2003 | B2 |
6569120 | Green | May 2003 | B1 |
6578577 | Bonadio et al. | Jun 2003 | B2 |
6579281 | Palmer et al. | Jun 2003 | B2 |
6582364 | Butler et al. | Jun 2003 | B2 |
6589167 | Shimomura et al. | Jul 2003 | B1 |
6589211 | MacLeod | Jul 2003 | B1 |
6607504 | Haarala et al. | Aug 2003 | B2 |
6613952 | Rambo | Sep 2003 | B2 |
6623426 | Bonadio et al. | Sep 2003 | B2 |
6627275 | Chen | Sep 2003 | B1 |
6663598 | Carrillo et al. | Dec 2003 | B1 |
6669674 | Macoviak et al. | Dec 2003 | B1 |
6676639 | Ternström | Jan 2004 | B1 |
6702787 | Racenet et al. | Mar 2004 | B2 |
6705989 | Cuschieri et al. | Mar 2004 | B2 |
6706050 | Giannadakis | Mar 2004 | B1 |
6714298 | Ryer | Mar 2004 | B2 |
6716201 | Blanco | Apr 2004 | B2 |
6723044 | Pulford et al. | Apr 2004 | B2 |
6723088 | Gaskill, III et al. | Apr 2004 | B2 |
6725080 | Melkent et al. | Apr 2004 | B2 |
6793621 | Butler et al. | Sep 2004 | B2 |
6794440 | Chen | Sep 2004 | B2 |
6796940 | Bonadio et al. | Sep 2004 | B2 |
6797765 | Pearce | Sep 2004 | B2 |
6800084 | Davison et al. | Oct 2004 | B2 |
6811546 | Callas et al. | Nov 2004 | B1 |
6814078 | Crook | Nov 2004 | B2 |
6814700 | Mueller et al. | Nov 2004 | B1 |
6817974 | Cooper et al. | Nov 2004 | B2 |
6830578 | O'Heeron et al. | Dec 2004 | B2 |
6837893 | Miller | Jan 2005 | B2 |
6840946 | Fogarty et al. | Jan 2005 | B2 |
6840951 | de la Torre et al. | Jan 2005 | B2 |
6846287 | Bonadio et al. | Jan 2005 | B2 |
6860463 | Hartley | Mar 2005 | B2 |
6863674 | Kasahara et al. | Mar 2005 | B2 |
6866861 | Luhman | Mar 2005 | B1 |
6867253 | Chen | Mar 2005 | B1 |
6869393 | Butler | Mar 2005 | B2 |
6878110 | Yang et al. | Apr 2005 | B2 |
6884253 | McFarlane | Apr 2005 | B1 |
6890295 | Michels et al. | May 2005 | B2 |
6895965 | Scarberry et al. | May 2005 | B2 |
6902541 | McNally et al. | Jun 2005 | B2 |
6902569 | Parmer et al. | Jun 2005 | B2 |
6908430 | Caldwell et al. | Jun 2005 | B2 |
6909220 | Chen | Jun 2005 | B2 |
6913609 | Yencho et al. | Jul 2005 | B2 |
6916310 | Sommerich | Jul 2005 | B2 |
6916331 | Mollenauer et al. | Jul 2005 | B2 |
6929637 | Gonzalez et al. | Aug 2005 | B2 |
6936037 | Bubb et al. | Aug 2005 | B2 |
6939296 | Ewers et al. | Sep 2005 | B2 |
6945932 | Caldwell et al. | Sep 2005 | B1 |
6958037 | Ewers et al. | Oct 2005 | B2 |
6972026 | Caldwell et al. | Dec 2005 | B1 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
6991602 | Nakazawa et al. | Jan 2006 | B2 |
6997909 | Goldberg | Feb 2006 | B2 |
7001397 | Davison et al. | Feb 2006 | B2 |
7008377 | Beane et al. | Mar 2006 | B2 |
7014628 | Bousquet | Mar 2006 | B2 |
7033319 | Pulford et al. | Apr 2006 | B2 |
7052454 | Taylor | May 2006 | B2 |
7056304 | Bacher et al. | Jun 2006 | B2 |
7056321 | Pagliuca et al. | Jun 2006 | B2 |
7067583 | Chen | Jun 2006 | B2 |
7077852 | Fogarty et al. | Jul 2006 | B2 |
7081089 | Bonadio et al. | Jul 2006 | B2 |
7083626 | Hart et al. | Aug 2006 | B2 |
7093599 | Chen | Aug 2006 | B2 |
7100614 | Stevens et al. | Sep 2006 | B2 |
7101353 | Lui et al. | Sep 2006 | B2 |
7105009 | Johnson | Sep 2006 | B2 |
7105607 | Chen | Sep 2006 | B2 |
7112185 | Hart et al. | Sep 2006 | B2 |
7118528 | Piskun | Oct 2006 | B1 |
7134929 | Chen | Nov 2006 | B2 |
7153261 | Wenchell | Dec 2006 | B2 |
7163510 | Kahle et al. | Jan 2007 | B2 |
7192436 | Sing et al. | Mar 2007 | B2 |
7193002 | Chen | Mar 2007 | B2 |
7195590 | Butler et al. | Mar 2007 | B2 |
7214185 | Rosney et al. | May 2007 | B1 |
7217277 | Parihar et al. | May 2007 | B2 |
7222380 | Chen | May 2007 | B2 |
7223257 | Shubayev et al. | May 2007 | B2 |
7223278 | Davison et al. | May 2007 | B2 |
7226484 | Chen | Jun 2007 | B2 |
7235062 | Brustad | Jun 2007 | B2 |
7235084 | Skakoon et al. | Jun 2007 | B2 |
7238154 | Ewers et al. | Jul 2007 | B2 |
7244244 | Racenet et al. | Jul 2007 | B2 |
7276075 | Callas et al. | Oct 2007 | B1 |
7290367 | Chen | Nov 2007 | B2 |
7294103 | Bertolero et al. | Nov 2007 | B2 |
7297106 | Yamada et al. | Nov 2007 | B2 |
7300399 | Bonadio et al. | Nov 2007 | B2 |
7316699 | McFarlane | Jan 2008 | B2 |
7331940 | Sommerich | Feb 2008 | B2 |
7338473 | Campbell et al. | Mar 2008 | B2 |
7344546 | Wulfman et al. | Mar 2008 | B2 |
7344547 | Piskun | Mar 2008 | B2 |
7344568 | Chen | Mar 2008 | B2 |
7377898 | Ewers et al. | May 2008 | B2 |
7390317 | Taylor et al. | Jun 2008 | B2 |
7393322 | Wenchell | Jul 2008 | B2 |
7412977 | Fields et al. | Aug 2008 | B2 |
7445597 | Butler et al. | Nov 2008 | B2 |
7473221 | Ewers et al. | Jan 2009 | B2 |
7481765 | Ewers et al. | Jan 2009 | B2 |
7537564 | Bonadio et al. | May 2009 | B2 |
7540839 | Butler et al. | Jun 2009 | B2 |
7559893 | Bonadio et al. | Jul 2009 | B2 |
7578832 | Johnson | Aug 2009 | B2 |
7645232 | Shluzas | Jan 2010 | B2 |
7650887 | Nguyen et al. | Jan 2010 | B2 |
7661164 | Chen | Feb 2010 | B2 |
7704207 | Albrecht et al. | Apr 2010 | B2 |
7717847 | Smith | May 2010 | B2 |
7727146 | Albrecht et al. | Jun 2010 | B2 |
7727225 | Broaddus et al. | Jun 2010 | B2 |
7736306 | Brustad et al. | Jun 2010 | B2 |
7749415 | Brustad et al. | Jul 2010 | B2 |
7753901 | Piskun et al. | Jul 2010 | B2 |
7758500 | Boyd et al. | Jul 2010 | B2 |
7766824 | Jensen et al. | Aug 2010 | B2 |
7811251 | Wenchell et al. | Oct 2010 | B2 |
7815567 | Albrecht et al. | Oct 2010 | B2 |
7837612 | Gill et al. | Nov 2010 | B2 |
7850667 | Gresham | Dec 2010 | B2 |
7867164 | Butler et al. | Jan 2011 | B2 |
7878974 | Brustad et al. | Feb 2011 | B2 |
7896889 | Mazzocchi et al. | Mar 2011 | B2 |
7909760 | Albrecht et al. | Mar 2011 | B2 |
7930782 | Chen | Apr 2011 | B2 |
20010037053 | Bonadio et al. | Nov 2001 | A1 |
20010047188 | Bonadio et al. | Nov 2001 | A1 |
20020002324 | McManus | Jan 2002 | A1 |
20020010389 | Butler et al. | Jan 2002 | A1 |
20020013542 | Bonadio et al. | Jan 2002 | A1 |
20020016607 | Bonadio et al. | Feb 2002 | A1 |
20020026230 | Moll et al. | Feb 2002 | A1 |
20020038077 | de la Torre et al. | Mar 2002 | A1 |
20020072762 | Bonadio et al. | Jun 2002 | A1 |
20020111536 | Cuschieri et al. | Aug 2002 | A1 |
20030004253 | Chen | Jan 2003 | A1 |
20030014076 | Mollenauer et al. | Jan 2003 | A1 |
20030028179 | Piskun | Feb 2003 | A1 |
20030040711 | Racenet et al. | Feb 2003 | A1 |
20030078478 | Bonadio et al. | Apr 2003 | A1 |
20030139756 | Brustad | Jul 2003 | A1 |
20030167040 | Bacher et al. | Sep 2003 | A1 |
20030187376 | Rambo | Oct 2003 | A1 |
20030192553 | Rambo | Oct 2003 | A1 |
20030225392 | McMichael et al. | Dec 2003 | A1 |
20030236505 | Bonadio et al. | Dec 2003 | A1 |
20030236549 | Bonadio et al. | Dec 2003 | A1 |
20040015185 | Ewers et al. | Jan 2004 | A1 |
20040024363 | Goldberg | Feb 2004 | A1 |
20040049099 | Ewers et al. | Mar 2004 | A1 |
20040049100 | Butler | Mar 2004 | A1 |
20040054353 | Taylor | Mar 2004 | A1 |
20040063833 | Chen | Apr 2004 | A1 |
20040068232 | Hart et al. | Apr 2004 | A1 |
20040070187 | Chen | Apr 2004 | A1 |
20040072942 | Chen | Apr 2004 | A1 |
20040073090 | Butler | Apr 2004 | A1 |
20040092795 | Bonadio et al. | May 2004 | A1 |
20040092796 | Butler et al. | May 2004 | A1 |
20040093018 | Johnson | May 2004 | A1 |
20040097793 | Butler et al. | May 2004 | A1 |
20040106942 | Taylor | Jun 2004 | A1 |
20040111061 | Curran | Jun 2004 | A1 |
20040127772 | Ewers et al. | Jul 2004 | A1 |
20040138529 | Wiltshire et al. | Jul 2004 | A1 |
20040143158 | Hart et al. | Jul 2004 | A1 |
20040154624 | Bonadio et al. | Aug 2004 | A1 |
20040167559 | Taylor et al. | Aug 2004 | A1 |
20040173218 | Yamada et al. | Sep 2004 | A1 |
20040215063 | Bonadio et al. | Oct 2004 | A1 |
20040230161 | Zeiner | Nov 2004 | A1 |
20040243144 | Bonadio et al. | Dec 2004 | A1 |
20040249248 | Bonadio et al. | Dec 2004 | A1 |
20040254426 | Wenchell | Dec 2004 | A1 |
20040260244 | Piechowicz et al. | Dec 2004 | A1 |
20040267096 | Caldwell et al. | Dec 2004 | A1 |
20050020884 | Hart et al. | Jan 2005 | A1 |
20050033246 | Ahlbert et al. | Feb 2005 | A1 |
20050059865 | Kahle et al. | Mar 2005 | A1 |
20050065475 | Hart et al. | Mar 2005 | A1 |
20050065543 | Kahle et al. | Mar 2005 | A1 |
20050090713 | Gozales et al. | Apr 2005 | A1 |
20050090716 | Bonadio et al. | Apr 2005 | A1 |
20050090717 | Bonadio et al. | Apr 2005 | A1 |
20050096695 | Olich | May 2005 | A1 |
20050131349 | Albrecht et al. | Jun 2005 | A1 |
20050148823 | Vaugh et al. | Jul 2005 | A1 |
20050155611 | Vaugh et al. | Jul 2005 | A1 |
20050159647 | Hart et al. | Jul 2005 | A1 |
20050192483 | Bonadio et al. | Sep 2005 | A1 |
20050192598 | Johnson et al. | Sep 2005 | A1 |
20050197537 | Bonadio et al. | Sep 2005 | A1 |
20050203346 | Bonadio et al. | Sep 2005 | A1 |
20050209510 | Bonadio et al. | Sep 2005 | A1 |
20050222582 | Wenchell | Oct 2005 | A1 |
20050240082 | Bonadio et al. | Oct 2005 | A1 |
20050241647 | Nguyen | Nov 2005 | A1 |
20050251124 | Zvuloni et al. | Nov 2005 | A1 |
20050261720 | Caldwell et al. | Nov 2005 | A1 |
20050267419 | Smith | Dec 2005 | A1 |
20050277946 | Greenhalgh | Dec 2005 | A1 |
20050283050 | Gundlapalli et al. | Dec 2005 | A1 |
20050288558 | Ewers et al. | Dec 2005 | A1 |
20050288634 | O'Heeron et al. | Dec 2005 | A1 |
20060020164 | Butler et al. | Jan 2006 | A1 |
20060020241 | Piskun et al. | Jan 2006 | A1 |
20060030755 | Ewers et al. | Feb 2006 | A1 |
20060041270 | Lenker | Feb 2006 | A1 |
20060047284 | Gresham | Mar 2006 | A1 |
20060047293 | Haberland et al. | Mar 2006 | A1 |
20060052669 | Hart | Mar 2006 | A1 |
20060084842 | Hart et al. | Apr 2006 | A1 |
20060106402 | McLucas | May 2006 | A1 |
20060129165 | Edoga et al. | Jun 2006 | A1 |
20060149137 | Pingleton et al. | Jul 2006 | A1 |
20060149306 | Hart et al. | Jul 2006 | A1 |
20060161049 | Beane et al. | Jul 2006 | A1 |
20060161050 | Butler et al. | Jul 2006 | A1 |
20060241651 | Wilk | Oct 2006 | A1 |
20060247498 | Bonadio et al. | Nov 2006 | A1 |
20060247499 | Butler et al. | Nov 2006 | A1 |
20060247500 | Voegele et al. | Nov 2006 | A1 |
20060247516 | Hess et al. | Nov 2006 | A1 |
20060247586 | Voegele et al. | Nov 2006 | A1 |
20060247673 | Voegele et al. | Nov 2006 | A1 |
20060247678 | Weisenburgh, II et al. | Nov 2006 | A1 |
20060258899 | Gill et al. | Nov 2006 | A1 |
20060264706 | Piskun | Nov 2006 | A1 |
20060270911 | Voegele et al. | Nov 2006 | A1 |
20070004968 | Bonadio et al. | Jan 2007 | A1 |
20070049966 | Bonadio et al. | Mar 2007 | A1 |
20070093695 | Bonadio et al. | Apr 2007 | A1 |
20070118175 | Butler et al. | May 2007 | A1 |
20070151566 | Kahle et al. | Jul 2007 | A1 |
20070156023 | Frasier et al. | Jul 2007 | A1 |
20070203398 | Bonadio et al. | Aug 2007 | A1 |
20070208312 | Norton et al. | Sep 2007 | A1 |
20070255219 | Vaugh et al. | Nov 2007 | A1 |
20070299387 | Williams et al. | Dec 2007 | A1 |
20080027476 | Piskun | Jan 2008 | A1 |
20080048011 | Weller | Feb 2008 | A1 |
20080097162 | Bonadio et al. | Apr 2008 | A1 |
20080097163 | Butler et al. | Apr 2008 | A1 |
20080200767 | Ewers et al. | Aug 2008 | A1 |
20080255519 | Piskun et al. | Oct 2008 | A1 |
20080281161 | Albrecht et al. | Nov 2008 | A1 |
20080281162 | Albrecht et al. | Nov 2008 | A1 |
20090012477 | Norton et al. | Jan 2009 | A1 |
20090036745 | Bonadio et al. | Feb 2009 | A1 |
20090069837 | Bonadio et al. | Mar 2009 | A1 |
20090093683 | Richard et al. | Apr 2009 | A1 |
20090093752 | Richard et al. | Apr 2009 | A1 |
20090131754 | Ewers et al. | May 2009 | A1 |
20090137879 | Ewers et al. | May 2009 | A1 |
20090149714 | Bonadio | Jun 2009 | A1 |
20090182279 | Wenchell et al. | Jul 2009 | A1 |
20090187079 | Albrecht et al. | Jul 2009 | A1 |
20090227843 | Smith et al. | Sep 2009 | A1 |
20090292176 | Bonadio et al. | Nov 2009 | A1 |
20090326330 | Bonadio et al. | Dec 2009 | A1 |
20100063362 | Bonadio et al. | Mar 2010 | A1 |
20100063364 | Bonadio et al. | Mar 2010 | A1 |
20100081880 | Widenhouse et al. | Apr 2010 | A1 |
20100081881 | Murray et al. | Apr 2010 | A1 |
20100081995 | Widenhouse et al. | Apr 2010 | A1 |
20100100043 | Racenet | Apr 2010 | A1 |
20100113882 | Widenhouse et al. | May 2010 | A1 |
20100217087 | Bonadio et al. | Aug 2010 | A1 |
20100228091 | Widenhouse et al. | Sep 2010 | A1 |
20100228092 | Ortiz et al. | Sep 2010 | A1 |
20100228094 | Ortiz et al. | Sep 2010 | A1 |
20100240960 | Richard | Sep 2010 | A1 |
20100249523 | Spiegel et al. | Sep 2010 | A1 |
20100249524 | Ransden et al. | Sep 2010 | A1 |
20100249525 | Shelton, IV et al. | Sep 2010 | A1 |
20100249694 | Choi et al. | Sep 2010 | A1 |
20100261972 | Widenhouse et al. | Oct 2010 | A1 |
20100261975 | Huey et al. | Oct 2010 | A1 |
20100286484 | Stellon et al. | Nov 2010 | A1 |
20100298646 | Stellon et al. | Nov 2010 | A1 |
20110021877 | Fortier et al. | Jan 2011 | A1 |
20110028891 | Okoniewski | Feb 2011 | A1 |
20110034935 | Kleyman | Feb 2011 | A1 |
20110034946 | Kleyman | Feb 2011 | A1 |
20110034947 | Kleyman | Feb 2011 | A1 |
20110071462 | Ewers et al. | Mar 2011 | A1 |
20110071463 | Ewers et al. | Mar 2011 | A1 |
Number | Date | Country |
---|---|---|
26 05 148 | Aug 1977 | DE |
33 36 279 | Jan 1986 | DE |
37 39 532 | Dec 1988 | DE |
37 37 121 | May 1989 | DE |
296 00 939 | Jun 1996 | DE |
19828009 | Dec 1999 | DE |
0113520 | Jul 1984 | EP |
0142262 | May 1985 | EP |
0 517 248 | Dec 1992 | EP |
0537768 | Apr 1993 | EP |
0 807 416 | Nov 1997 | EP |
0 849 517 | Jun 1998 | EP |
0950376 | Oct 1999 | EP |
1118657 | Jul 2001 | EP |
1 125 552 | Aug 2001 | EP |
1312318 | May 2003 | EP |
1 407 715 | Apr 2004 | EP |
2044889 | Apr 2009 | EP |
1456623 | Sep 1966 | FR |
1151993 | May 1969 | GB |
1355611 | Jun 1974 | GB |
1372491 | Oct 1974 | GB |
1379772 | Jan 1975 | GB |
1400808 | Jul 1975 | GB |
1407023 | Sep 1975 | GB |
1482857 | Aug 1977 | GB |
1496696 | Dec 1977 | GB |
2071502 | Sep 1981 | GB |
2255019 | Oct 1992 | GB |
2275420 | Aug 1994 | GB |
2298906 | Sep 1996 | GB |
930649 | Sep 1993 | IE |
930650 | Sep 1993 | IE |
S940150 | Feb 1994 | IE |
S940613 | Aug 1994 | IE |
S940960 | Dec 1994 | IE |
S950055 | Jan 1995 | IE |
S950266 | Apr 1995 | IE |
S75368 | Aug 1997 | IE |
S960196 | Aug 1997 | IE |
S970810 | Nov 1997 | IE |
991010 | Jul 2000 | IE |
990218 | Nov 2000 | IE |
990219 | Nov 2000 | IE |
990220 | Nov 2000 | IE |
990660 | Feb 2001 | IE |
990795 | Mar 2001 | IE |
10-108868 | Apr 1998 | JP |
11-290327 | Oct 1999 | JP |
2001-61850 | Mar 2001 | JP |
2002-28163 | Jan 2002 | JP |
02003 235879 | Aug 2003 | JP |
2004-195037 | Jul 2004 | JP |
1342485 | Jan 1997 | SU |
WO 8606272 | Nov 1986 | WO |
WO 8606316 | Nov 1986 | WO |
WO 9211880 | Jul 1992 | WO |
WO 9221292 | Dec 1992 | WO |
WO 9305740 | Apr 1993 | WO |
WO 9314801 | Aug 1993 | WO |
WO 9404067 | Mar 1994 | WO |
WO 9422357 | Oct 1994 | WO |
WO 9505207 | Feb 1995 | WO |
WO 9507056 | Mar 1995 | WO |
WO 9522289 | Aug 1995 | WO |
WO 9524864 | Sep 1995 | WO |
WO 9527445 | Oct 1995 | WO |
WO 9527468 | Oct 1995 | WO |
WO 9636283 | Nov 1996 | WO |
WO 9711642 | Apr 1997 | WO |
WO 9732514 | Sep 1997 | WO |
WO 9732515 | Sep 1997 | WO |
WO 9742889 | Nov 1997 | WO |
WO 9819853 | May 1998 | WO |
WO 9835614 | Aug 1998 | WO |
WO 9848724 | Nov 1998 | WO |
WO 9903416 | Jan 1999 | WO |
WO 9915068 | Apr 1999 | WO |
WO 9916368 | Apr 1999 | WO |
WO 9922804 | May 1999 | WO |
WO 9925268 | May 1999 | WO |
WO 9929250 | Jun 1999 | WO |
WO 0032116 | Jun 2000 | WO |
WO 0032117 | Jun 2000 | WO |
WO 0032119 | Jun 2000 | WO |
WO 0032120 | Jun 2000 | WO |
WO 0035356 | Jun 2000 | WO |
WO 0054675 | Sep 2000 | WO |
WO 0054676 | Sep 2000 | WO |
WO 0054677 | Sep 2000 | WO |
WO 0108563 | Feb 2001 | WO |
WO 0108581 | Feb 2001 | WO |
WO 0126558 | Apr 2001 | WO |
WO 0126559 | Apr 2001 | WO |
WO 0145568 | Jun 2001 | WO |
WO 0149363 | Jul 2001 | WO |
WO 0191652 | Dec 2001 | WO |
WO 0207611 | Jan 2002 | WO |
WO 0217800 | Mar 2002 | WO |
WO 0234108 | May 2002 | WO |
WO 03011153 | Feb 2003 | WO |
WO 03011551 | Feb 2003 | WO |
WO 03026512 | Apr 2003 | WO |
WO 03032819 | Apr 2003 | WO |
WO 03034908 | May 2003 | WO |
WO 03061480 | Jul 2003 | WO |
WO 03077726 | Sep 2003 | WO |
WO 03103548 | Dec 2003 | WO |
WO 2004026153 | Apr 2004 | WO |
WO 2004030547 | Apr 2004 | WO |
WO 2004075730 | Sep 2004 | WO |
WO 2004075741 | Sep 2004 | WO |
WO 2004075930 | Sep 2004 | WO |
WO 2005009257 | Feb 2005 | WO |
WO 2005034766 | Apr 2005 | WO |
WO 2005089661 | Sep 2005 | WO |
WO 2006040748 | Apr 2006 | WO |
WO 2006059318 | Jun 2006 | WO |
WO 2006100658 | Sep 2006 | WO |
WO 2008015566 | Feb 2008 | WO |
WO 2008093313 | Aug 2008 | WO |
WO 2008121294 | Oct 2008 | WO |
WO 2010082722 | Jul 2010 | WO |
WO 2010104259 | Sep 2010 | WO |
Number | Date | Country | |
---|---|---|---|
20110071463 A1 | Mar 2011 | US |
Number | Date | Country | |
---|---|---|---|
60241958 | Oct 2000 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12360710 | Jan 2009 | US |
Child | 12960458 | US | |
Parent | 11244647 | Oct 2005 | US |
Child | 12360710 | US | |
Parent | 10381220 | US | |
Child | 11244647 | US |